Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05090657 · ClinicalTrials.gov registry record · Phase 2
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
A Phase 2 study, sponsored by Ondine Biomedical.
- Completed
- Registry status
- Phase 2
- Development phase
- 322
- Enrollment target
NCT05090657 is a Phase 2 study that has completed, run by Ondine Biomedical. The registered enrollment target is 322 participants.
The verdict
NCT05090657, a Phase 2 study, has completed, sponsored by Ondine Biomedical.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 322 participants
- Enrollment target
Study Summary
This is a Phase 2 single-center, open-label, single-arm, study of a microbiological endpoint using antimicrobial photodynamic therapy (aPDT) for nasal disinfection in all patients (universal) presenting for surgery at an acute care hospital for a wide range of surgical procedures.
Interventions
- COMBINATION_PRODUCT methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2022-02-04 |
| Est. Completion | 2022-08-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05090657
The ClinicalTrials.gov registry entry for NCT05090657 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ondine Biomedical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation is the first listed.
NCT05090657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05090657 about?
NCT05090657 is a clinical study titled "Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures". This is a Phase 2 single-center, open-label, single-arm, study of a microbiological endpoint using antimicrobial photodynamic therapy (aPDT) for nasal disinfection in all patients (universal) presenting for surgery at an acute care hospital for a wide range of surgical procedures.
What is the current status of trial NCT05090657?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 322 participants. The study started on 2022-02-04. Estimated completion is 2022-08-06.
What interventions are being tested in trial NCT05090657?
The interventions under investigation include: methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05090657?
This trial is sponsored by Ondine Biomedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.